Abstract
Biodegradable polyethylene glycol (PEG)-coated nanospheres have important therapeutic applications as injectable blood persistent particulate carriers for the controlled release of drugs, site-specific drug delivery, or medical imaging. They are obtained by emulsion/solvent evaporation (Gref et al., 1994), solvent displacement (Bazile et al., 1995), or block copolymer adsorption on preformed particles (Stolnick et al., 1994). The hydrophilic PEG coating reduces the surface charge, avoids plasma protein adsorption, minimizes the interaction with phagocytic cells and therefore increases the blood circulation time. The blood half-life of such particles is increased to up to six hours in rats (Bazile et al., 1995), compared to uncoated ones, which are removed within minutes, essentially by macrophages located in the liver and spleen. These recent nanospheres have essential advantages over other long-circulating systems, such as increased stability, resistance against plasma protein insertion in the matrix, and the possibility of obtaining controlled release, on the basis of an appropriate choice of the core composition.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Appel, R.D., Hochstrasser, D.F., Funk, M., Vargas, J.R., Pellegrini, C., Müller, A.F. and Scherrer, J.R., 1991, The MELANIE project: From a biopsy to automatic protein map interpretation by computer, Electrophoresis 12:722.
Bazile, D., Prud’homme, C., Bassoullet, M.T., Marlard, M, Spenlehauer, G. and Veillard, M., 1995, Stealth MePEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system, J. Pharm. Sci. 84:493.
Blanco, M.D. and Alonso, M.J., Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres, Eur. J. Pharm. Biopharm., in press.
Blunk, T., Hochstrasser, D.F., Sanchez, J.C., Müller B.W., and Müller, R.H., 1993, Colloidal carriers for intravenous drug targeting: Plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis, Electrophoresis, 14:1382.
Blunk, T., 1994, Ph. D. thesis, University of Kiel, Germany.
Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L.H. and Langer, R., 1991, Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres, Pharm. Res., 8:713.
Delattre, J., Couvreur, P., Puisieux, F. and Philippot, J.-R., 1993, Les liposomes, aspects technologiques, biologiques et pharmacologiques, Ed. InanospheresERM, Tec &Doc Lavoisier, Paris.
Golaz, O., Hughes, G.J., Frutiger, S., Paquet, N., Bairoch, A., Pasquali, C, Sanchez, J.-C, Tissot, J.-D., Appel, R.D., Walzer, C, Balant, L., and Hochstrasser, DF., 1993, Plasma and red blood cell protein maps: Update 1993, Electrophoresis 14:1223.
Gombotz, W.R., Guanghui, W., Horbett, T.A., and Hoffmann, A.S., 1991, Protein adsorption to poly (ethylene oxide) surfaces, J. Biomed. Mater. Res., 25:1547.
Gref, R., Minamitake, Y., Peracchia, M.T., Trubetskoy, V., Torchilin, V., and Langer, R., 1994, Biodegradable long-circulating nanospheres, Science 263:1600.
Gref, R., Domb, A., Quellec, P., Blunk, T., Müller, R.H., Verbavatz, J.M., and Langer, R., 1995, The controlled intravenous administration of drugs using PEG-coated sterically stabilized nanospheres, Adv. Drug Deliv. Rev. 16:215.
Hochstrasser, D.F., Harrington, M.G., Hochstrasser, A.-C., Miller, M.J., and Merril, C.R., 1988, Methods for increasing the resolution of two-dimensional protein electrophoresis, Anal. Biochem., 173:424.
Hora, M.S., Rana, R.K., Nunberg, J.H., Tice, T.R., Gilley, R.M. and Hudson, M.E., 1990, Release of human serum albumin from poly(lactide-co-glycolide) microspheres, Pharm. Res., 7:1190.
Hrkach, J.S., Peracchia M.T., Domb, A., Lotan N., and R. Langer, Nanotechnology for biomaterials engineering: structural characterization of amphiphilic polymeric nanospheres using 1H-NMR spectroscopy, Biomaterials, in press.
Jeon, S.I., Lee, J.H., Andrade, J.D., and De Gennes, P.G., 1991, Protein-surface interactions in the presence of polyethylene oxide, I. Simplified theory, J. Colloid Interf. Sci., 142:149.
Park, T.G., Lu, W. and Crotts, G., 1995, Importance of the in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated P(DL-LA-co-GA) MS, J. Controlled Rel. 33:211.
Peracchia, M.T., Gref, R., Minamitake, Y., Domb, A., Lotan, N., and Langer, R., 1997, PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: investigation of their drug encapsulation and release characteristics, J. Controlled Rel. 46:223.
Peterson, G.L., 1977, A simplification of the protein assay method of Lowry and al. which is more generally applicable, Anal. Biochem., 83:346.
Quellec, P., Gref, R., Calvo, P., Alonso, M.J., and Dellacherie, E., 1996, Encapsulation of a model protein and of a hydrophobic drug into long-circulating biodegradable nanospheres, Procced. Intern. Symp. Control. Rel. Bioact. Mater., 23:815.
Sharif, S. and O’Hagan, DS., 1995, A comparison of alternative methods for the determination of the levels of proteins entrapped in PLGA microparticles, Int. J. Pharm. 115:259.
Stolnick, S., Dunn, S.E., Garnett, M.C., Davies, M.C., Coombes, A.G.A., Taylor, D.C., Irving, M.P., Purkiss, S.C., Tadros, T.F., Davis, S. and Ilium, L., 1994, Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers, Pharm. Res. 11:1800.
Swendeman, S.P., Tobio, M, Joworowicz, M., Alonso, M.J. and Langer, R., New strategies for the micro-encapsulation of tetanus vaccine, J. Microencapsulation, in press.
Tan, J., Butterfield, D., Voycheck, C, Caldwell, C. and Li, J., 1993, Surface modification of nanoparticles by PEO/PPO block copolymers to minimize the interactions with blood components and prolong blood circulation in rats, Biomaterials, 14:823.
Vittaz, M., Bazile, D., Spenlehauer, G., Verrecchia, T., Veillard, M., Puisieux, F., and Labarre, D., 1996, Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators, Biomaterials, 17:1575.
Youxin, L., Volland, C. and Kissel, T., 1994, In vitro degradation and BSA release of P(L-LA)-POE-P(L-LA) and PLGA-POE-PLGA, J. Controlled Rel., 32:121.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gref, R. et al. (1998). PEG-Coated Nanospheres: Surface Optimization and Therapeutic Applications. In: Gregoriadis, G., McCormack, B. (eds) Targeting of Drugs 6. NATO ASI Series, vol 300. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0127-9_24
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0127-9_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0129-3
Online ISBN: 978-1-4899-0127-9
eBook Packages: Springer Book Archive